ResMed (RMD) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $252.86 -0.08%
Revenue Growth %: +6.9%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +6.9%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Top restaurant stocks to watch, according to Raymond James
- AI chip sell-off is ‘unmoored from fundamentals,’ LYNX says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
